Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

[at noodls] – MIAMI, FL, October 24, 2012 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced three-year results of a pivotal … more

View todays social media effects on EW

View the latest stocks trending across Twitter. Click to view dashboard

Share this post